HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flora Jow Selected Research

1- (6- (4- fluorophenyl)pyridin- 3- yl)- 3- (4- piperidin- 1- ylbutyl)urea

12/2011Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Flora Jow Research Topics

Disease

3Schizophrenia (Dementia Praecox)
11/2012 - 03/2009
3Cognitive Dysfunction
11/2012 - 06/2010
2Alzheimer Disease (Alzheimer's Disease)
11/2012 - 03/2009
1Seizures (Absence Seizure)
03/2008
1Ischemic Stroke
01/2008
1Nervous System Diseases (Neurological Disorders)
10/2004

Drug/Important Bio-Agent (IBA)

3alpha7 Nicotinic Acetylcholine ReceptorIBA
12/2011 - 03/2009
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2012 - 12/2011
1Antipsychotic Agents (Antipsychotics)IBA
12/2011
11- (6- (4- fluorophenyl)pyridin- 3- yl)- 3- (4- piperidin- 1- ylbutyl)ureaIBA
12/2011
1Pentylenetetrazole (Metrazol)IBA
03/2008
1Sirolimus (Rapamycin)FDA Link
01/2008
1LigandsIBA
01/2008
1ImmunophilinsIBA
01/2008
1TOR Serine-Threonine KinasesIBA
01/2008
1Pharmaceutical PreparationsIBA
10/2004